Clinical TrialID 6876
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
NCT04361708
Pancreatic Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Adenocarcinoma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6876
- Evidence Id
- 6876
- Core Evidence Id
- 6876
- Source Clinical Trial Id
- 6868
- Herb2 Clinical Trial Id
- HBCT006868
- Nct Id
- NCT04361708
- Title
- Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
- Status
- Recruiting
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Pancreatic Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Adenocarcinoma
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Oxaliplatin|DRUG: Docetaxel|DRUG: Leucovorin|DRUG: Irinotecan|DRUG: 5-Fluorouracil
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 54
- Outcome Measure
- The maximum dose tolerated, To determine the maximum tolerated dose in the first month of therapy in each of the three main genotype groups (low, intermediate, and high risk) using genotype-guided dosing of irinotecan as part of the I-FLOAT regimen, 1 month
- Sponsor Collaborator
- University of Chicago
- Funded By
- OTHER
- Location
- The University of Chicago, Chicago, Illinois, 60637, United States
- Other Id
- IRB19-1292
- Start Date
- 2020-05-08
- Primary Completion Date
- 2025-06
- Completion Date
- 2027-05
- First Posted
- 2020-04-24
- Results First Posted
- Last Update Posted
- 2024-09-19
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT04361708
- Title Cn
- Title En
- Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
- Bilingual Status
- semi_complete